Records 1 - 3
| Outcome of unexpected adnexal neoplasia discovered during risk reduction salpingo-oophorectomy in women with germ-line BRCA1 or BRCA2 mutations.
Gynecologic oncology 2014 Feb 132 (2): 280-6.
Conner James R, Meserve Emily, Pizer Ellen, Garber Judy, Roh Michael, Urban Nicole, Drescher Charles, Quade Bradley J, Muto Michael, Howitt Brooke E, Pearlman Mark D, Berkowitz Ross S, Horowitz Neil, Crum Christopher P, Feltmate Colle
| Germline BRCA1 and BRCA2 mutations in ovarian cancer: utility of a histology-based referral strategy.
Obstetrics and gynecology 2012 Aug 120 (2 Pt 1): 235-40.
Schrader Kasmintan A, Hurlburt Jane, Kalloger Steve E, Hansford Samantha, Young Sean, Huntsman David G, Gilks C Blake, McAlpine Jessica
| High risk for ovarian cancer in a prospective series is restricted to BRCA1/2 mutation carriers.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008 Nov 14 (22): 7569-73.
Maehle Lovise, Apold Jaran, Paulsen Torbjørn, Hagen Bjørn, Løvslett Kjell, Fiane Bent, Van Ghelue Marijke, Clark Neal, Møller P